IDXX · earnings call history
IDEXX Laboratories Q1 FY26 — Strong Diagnostics Growth Despite Clinical Visit Headwinds
Read the briefIDEXX Laboratories Q4 FY25 — Strong Growth Driven by Innovation and Premium Instrument Placements
Read the briefIDEXX Q3 FY25 — Strong CAG Diagnostics Growth & InVue Dx Momentum
Read the briefIDEXX Q4 FY24 — Strong Q4 Performance Driven by Innovation and International Growth Amidst US Clinical Visit Headwinds
Read the briefBrowse all US companies on the earnings-call register.